Eloxx Pharmaceuticals Q3 EPS $(0.32) Beats $(0.39) Estimate

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent.

Benzinga · 11/05/2019 21:15

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent.